vimarsana.com

Latest Breaking News On - Vectivbio holding - Page 1 : vimarsana.com

Analyzing TScan Therapeutics (NASDAQ:TCRX) & VectivBio (NASDAQ:VECT)

VectivBio (NASDAQ:VECT – Get Free Report) and TScan Therapeutics (NASDAQ:TCRX – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations. Risk & Volatility VectivBio has a beta of 0.08, […]

Switzerland
Waltham
Massachusetts
United-states
Ironwood-pharmaceuticals-inc
Tscan-therapeutics-inc
Amgen
Vectivbio-holding
Novartis-institutes-for-biomedical-research-inc
Get-free-report
Ironwood-pharmaceuticals

Ironwood Announces the Completion of Squeeze-Out Merger With VectivBio

12.12.2023 - Ironwood Pharmaceuticals, Inc. (“Ironwood”) (Nasdaq: IRWD), a GI-focused healthcare company, today announced the successful completion of the squeeze-out merger under Swiss law (the “Squeeze-Out Merger”) pursuant to which VectivBio Holding AG .

Boston
Massachusetts
United-states
Switzerland
Swiss
Nasdaq
Drug-administration
Exchange-commission-on
Ironwood-pharmaceuticals-nasdaq
Vectivbio-holding-ag
Ironwood-pharmaceuticals-registereda-stock

Ironwood Pharma (IRWD) Presents Positive Final Data from STARS Nutrition

Ironwood Pharma (IRWD) Presents Positive Final Data from STARS Nutrition
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Switzerland
Massachusetts
United-states
Boston
Beth-calitri
Tim-vanuytsel
Matt-roache
Greg-martini
Jana-noeldeke
Transplantation-center
Nasdaq
Ironwood-pharmaceuticals-inc

Virtu Financial LLC Acquires New Position in VectivBio Holding AG (NASDAQ:VECT)

Virtu Financial LLC purchased a new stake in VectivBio Holding AG (NASDAQ:VECT – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 41,411 shares of the company’s stock, valued at approximately $699,000. Other hedge funds have also made changes to […]

Marshall-wace
Gilder-gagnon-howe-co
Virtu-financial
Citadel-advisors
Regency-capital-management-inc
Harvest-management
Vectivbio-company-profile
Vectivbio-holding
Free-report
Capital-management
Gilder-gagnon-howe

Ironwood Pharmaceuticals Reports Second Quarter 2023 Results; Raises Full Year 2023 LINZESS® U.S. Net Sales and Ironwood Revenue Guidance

– LINZESS EUTRx prescription demand growth increased 9% year-over-year; LINZESS U.S. net sales of $270 million, an increase of 9% year-over-year – – Expands clinical utility of LINZESS with.

Canada
Switzerland
Japan
United-states
Boston
Massachusetts
China
America
Swiss
Tom-mccourt
Acquisition-of-vectivbio-holding-ag
Pharmaceuticals-development-company-inc

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.